Where Will Cameco Stock Be in 5 Years?
Cameco (NYSE: CCJ) isn’t exactly the kind of stock you…
Buy
73
FMS Quote, Financials, Valuation and Earnings
Last price:
$28.60
Seasonality move
:
-0.35%
Day range:
$28.77 - $29.12
52-week range:
$17.93 - $30.46
Dividend yield:
2.74%
P/E ratio:
25.20x
P/S ratio:
0.81x
P/B ratio:
1.09x
Volume:
837K
Avg. volume:
539.5K
1-year change:
34.93%
Market cap:
$16.9B
Revenue:
$20.9B
EPS (TTM):
$1.14
Analysts' Opinion
-
Consensus RatingFresenius Medical Care AG has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 4 Hold ratings, and 1 Sell rating.
-
Price Target DownsideAccording to analysts' consensus price target of $26.67, Fresenius Medical Care AG has an estimated downside of -5.2% from its current price of $28.78.
-
Price Target UpsideAccording to analysts, the highest upside price target is $31.98 representing -100% upside increase from its current price of $28.78.
Fair Value
-
According to the consensus of 6 analysts, Fresenius Medical Care AG has -5.2% downside to fair value with a price target of $26.67 per share.
FMS vs. S&P 500
-
Over the past 5 trading days, Fresenius Medical Care AG has underperformed the S&P 500 by -2.41% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Fresenius Medical Care AG does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Fresenius Medical Care AG has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Fresenius Medical Care AG reported revenues of $5.1B.
Earnings Growth
-
Fresenius Medical Care AG has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Fresenius Medical Care AG reported earnings per share of $0.27.
Enterprise value:
23.9B
EV / Invested capital:
0.99x
Price / LTM sales:
0.81x
EV / EBIT:
14.32x
EV / Revenue:
1.14x
PEG ratio (5yr expected):
0.91x
EV / Free cash flow:
12.92x
Price / Operating cash flow:
9.13x
Enterprise value / EBITDA:
9.56x
Gross Profit (TTM):
$5.1B
Return On Assets:
1.85%
Net Income Margin (TTM):
3.18%
Return On Equity:
4.05%
Return On Invested Capital:
3%
Operating Margin:
7.82%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $20.4B | $21.1B | $20.9B | $5.1B | $5.1B | |
| Gross Profit | $5.1B | $5.4B | $5.1B | $1.3B | $1.2B | |
| Operating Income | $1.5B | $1.7B | $1.8B | $392.6M | $401.7M | |
| EBITDA | $3.5B | $2.6B | $2.5B | $840.8M | $779.4M | |
| Diluted EPS | $1.06 | $0.89 | $1.14 | $0.13 | $0.27 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $9.1B | $9B | $9.3B | $10B | $8.6B | |
| Total Assets | $38.9B | $38.8B | $38.7B | $37.1B | $35.4B | |
| Current Liabilities | $8.5B | $7.1B | $7.1B | $6.7B | $5.9B | |
| Total Liabilities | $23.4B | $22.5B | $22.1B | $20.7B | $18.6B | |
| Total Equity | $15.5B | $16.2B | $16.6B | $16.3B | $16.8B | |
| Total Debt | $9.7B | $9.6B | $9.5B | $8.6B | $7.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.3B | $2.8B | $2.6B | $138.3M | $171.3M | |
| Cash From Investing | -$713.1M | -$488.1M | -$131.6M | -$74.3M | -$113.9M | |
| Cash From Financing | -$1.4B | -- | -- | -$314.6M | -$146M | |
| Free Cash Flow | $1.5B | $2.1B | $1.9B | -$7.2M | $18M | |
FMS
Sector
Market Cap
$16.9B
$34M
Price % of 52-Week High
94.49%
44.85%
Dividend Yield
2.74%
0%
Shareholder Yield
--
-0.66%
1-Year Price Total Return
34.93%
-40.27%
Beta (5-Year)
0.854
0.653
Dividend yield:
2.74%
Annualized payout:
$0.64
Payout ratio:
--
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$29.27
200-day SMA
Buy
Level
$22.82
Bollinger Bands (100)
Buy
Level
22.79 - 26.63
Chaikin Money Flow
Buy
Level
64.1M
20-day SMA
Buy
Level
$28.01
Relative Strength Index (RSI14)
Buy
Level
60.95
ADX Line
Buy
Level
34.54
Williams %R
Neutral
Level
-62.9213
50-day SMA
Buy
Level
$25.79
MACD (12, 26)
Buy
Level
1.13
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Sell
Level
-2.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.7301)
Sell
CA Score
(Annual)
Level (-0.4212)
Buy
Beneish M-Score
(Annual)
Level (-2.7305)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.018)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three quarters of sales while the balance is generated from medical technology products that enable dialysis treatments.
Stock Forecast FAQ
In the current month, FMS has received 1 Buy ratings 4 Hold ratings, and 1 Sell ratings. The FMS average analyst price target in the past 3 months is $26.67.
-
Where Will Fresenius Medical Care AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Fresenius Medical Care AG share price will drop to $26.67 per share over the next 12 months.
-
What Do Analysts Say About Fresenius Medical Care AG?
Analysts are divided on their view about Fresenius Medical Care AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Fresenius Medical Care AG is a Sell and believe this share price will rise from its current level to $21.18.
-
What Is Fresenius Medical Care AG's Price Target?
The price target for Fresenius Medical Care AG over the next 1-year time period is forecast to be $26.67 according to 6 Wall Street analysts, 1 of them rates the stock a Buy, 1 rates the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is FMS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Fresenius Medical Care AG is a Hold. 4 of 6 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of FMS?
You can purchase shares of Fresenius Medical Care AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Fresenius Medical Care AG shares.
-
What Is The Fresenius Medical Care AG Share Price Today?
Fresenius Medical Care AG was last trading at $28.60 per share. This represents the most recent stock quote for Fresenius Medical Care AG. Yesterday, Fresenius Medical Care AG closed at $28.78 per share.
-
How To Buy Fresenius Medical Care AG Stock Online?
In order to purchase Fresenius Medical Care AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth
Microsoft (NASDAQ:MSFT) has been among the top growth stocks of…
Is Tesla Stock Overvalued or a Buy for the Next Decade?
Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
10
EXOD alert for May 29
Exodus Movement [EXOD] is up 17.31% over the past day.
Buy
80
SBET alert for May 29
SharpLink Gaming [SBET] is up 181.07% over the past day.
Buy
100
BOX alert for May 29
Box [BOX] is up 1.38% over the past day.
